PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för mesulergine. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

13 hits

Bibliografisk träff 2013-04-01

Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties.

Bono F, De Smet F, Herbert C, De Bock K, Georgiadou M, Fons P, Tjwa M, Alcouffe C, Ny A, Bianciotto M, Jonckx B, Murakami M, Lanahan AA, Michielsen C, Sibrac D, Dol-Gleizes F, Mazzone M, Zacchigna S, Herault JP, Fischer C, Rigon P, Ruiz de Almodovar C, Claes F, Blanc I, Poesen K, Zhang J, Segura I, Gueguen G, Bordes MF, Lambrechts D, Broussy R, van de Wouwer M, Michaux C, Shimada T, Jean I, Blacher S, Noel A, Motte P, Rom E, Rakic JM, Katsuma S, Schaeffer P, Yayon A, Van Schepdael A, Schwalbe H, Gervasio FL, Carmeliet G, Rozensky J, Dewerchin M, Simons M, Christopoulos A, Herbert JM, Carmeliet P.

Cancer Cell · research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1016/j.ccr.2013.02.019

Bibliografisk träff 2012-02-01

Influence of serotonergic 5-HT2C receptor antagonist mesulergine in the reversal of memory deficits induced by mCPP.

Khaliq S, Haider S, Saleem S, Memon Z, Haleem DJ.

J Coll Physicians Surg Pak · comparative study; journal article · DOI 02.2012/jcpsp.7579

Bibliografisk träff 2011-01-01

Reversal of haloperidol-induced motor deficits by mianserin and mesulergine in rats.

Shireen E, Haleem DJ.

Pak J Pharm Sci · research support, non-u.s. gov't; journal article

Bibliografisk träff 1988-01-01

Stimulus generalization of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) to propranolol, pindolol, and mesulergine.

Glennon RA, Pierson ME, McKenney JD.

Pharmacol Biochem Behav · comparative study; journal article · DOI 10.1016/0091-3057(88)90296-1

Bibliografisk träff 1987-01-01

Antihypertensive effects of mesulergine: further evidence for a peripheral site of action of dopamine agonists.

Begaud B, Dang Tran L, Montastruc JL, Montastruc P.

Fundam Clin Pharmacol · journal article · DOI 10.1111/j.1472-8206.1987.tb00554.x

Bibliografisk träff 1986-01-01

Mesulergine (CU 32-085) in the treatment of Parkinson's disease.

Rascol A, Montastruc JL, Rascol O, Senard JM.

Clin Neuropharmacol · journal article · DOI 10.1097/00002826-198604000-00005

Bibliografisk träff 1985-08-01

Parkinson's disease: a comparison of mesulergine and bromocriptine.

Burton K, Larsen TA, Robinson RG, Bratty PJ, Martin WR, Schulzer M, Calne DB.

Neurology · comparative study; clinical trial; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1212/wnl.35.8.1205

Bibliografisk träff 1985-02-01

Placebo-controlled study of mesulergine in Parkinson's disease.

Jankovic J, Orman J, Jansson B.

Neurology · controlled clinical trial; clinical trial; journal article · DOI 10.1212/wnl.35.2.161

Bibliografisk träff 1985-01-01

Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism.

Baas H, Schneider E, Fischer PA, Japp G.

J Neural Transm · controlled clinical trial; clinical trial; journal article · DOI 10.1007/bf01259344

Bibliografisk träff 1984-11-01

Mesulergine, a new dopamine agonist: effects on anterior pituitary function and kinetics.

Borges JL, Schran HF, Evans WS, Rogol AD, Kaiser DL, MacLeod RM, Boyett RL, Elton RL, Thorner MO.

Clin Pharmacol Ther · comparative study; research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1038/clpt.1984.242

Bibliografisk träff 1984-11-01

Mechanism of action and tolerance of mesulergine.

Lamberts SW, Klÿn JG, Oosterom R.

Clin Pharmacol Ther · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1038/clpt.1984.231

Bibliografisk träff 1984-01-01

Dopaminergic properties of mesulergine (CU 32-085) and its metabolites.

Enz A, Donatsch P, Nordmann R.

J Neural Transm · comparative study; journal article · DOI 10.1007/bf01249095

Bibliografisk träff 1983-11-01

Mesulergine and its 1,20-N,N-bidemethylated metabolite interact directly with D1- and D2-receptors.

Markstein R.

Eur J Pharmacol · journal article · DOI 10.1016/0014-2999(83)90272-8